Evidence map›Paper›PMID 32362896›Full record

ArticleFrontiers in immunology2020

Seeking Windows of Opportunity to Shape Lifelong Immune Health: A Network-Based Strategy to Predict and Prioritize Markers of Early Life Immune Modulation.

Jolanda H M van Bilsen, Remon Dulos, Mariël F van Stee, Marie Y Meima, Tanja Rouhani Rankouhi, Lotte Neergaard Jacobsen, Anne Staudt Kvistgaard, Jossie A Garthoff, Léon M J Knippels, Karen Knipping and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Jolanda H M van BilsenNetherlands Organisation for Applied Scientific Research (TNO), Zeist, Netherlands.
Remon DulosNetherlands Organisation for Applied Scientific Research (TNO), Zeist, Netherlands.
Mariël F van SteeNetherlands Organisation for Applied Scientific Research (TNO), Zeist, Netherlands.
Marie Y MeimaNetherlands Organisation for Applied Scientific Research (TNO), Zeist, Netherlands.
Tanja Rouhani RankouhiNetherlands Organisation for Applied Scientific Research (TNO), Zeist, Netherlands.
Lotte Neergaard JacobsenArla Foods Ingredients, Aarhus, Denmark.
Anne Staudt KvistgaardArla Foods Ingredients, Aarhus, Denmark.
Jossie A GarthoffDanone Food Safety Center, Utrecht, Netherlands.
Léon M J KnippelsDanone Nutricia Research, Utrecht, Netherlands.
Karen KnippingDanone Nutricia Research, Utrecht, Netherlands.
Geert F HoubenNetherlands Organisation for Applied Scientific Research (TNO), Zeist, Netherlands.
Lars VerschurenNetherlands Organisation for Applied Scientific Research (TNO), Zeist, Netherlands.
Marjolein MeijerinkNetherlands Organisation for Applied Scientific Research (TNO), Zeist, Netherlands.
Shaji KrishnanNetherlands Organisation for Applied Scientific Research (TNO), Zeist, Netherlands.
Netherlands Organisation for Applied Scientific Research · NLArla Foods (Denmark) · DKDanone (Netherlands) · NLNutricia Research (Netherlands) · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A healthy immune status is strongly conditioned during early life stages. Insights into the molecular drivers of early life immune development and function are prerequisite to identify strategies to enhance immune health. Even though several starting points for targeted immune modulation have been identified and are being developed into prophylactic or therapeutic approaches, there is no regulatory guidance on how to assess the risk and benefit balance of such interventions. Six early life immune causal networks, each compromising a different time period in early life (the 1st, 2nd, 3rd trimester of gestations, birth, newborn, and infant period), were generated. Thereto information was extracted and structured from early life literature using the automated text mining and machine learning tool: Integrated Network and Dynamical Reasoning Assembler (INDRA). The tool identified relevant entities (e.g., genes/proteins/metabolites/processes/diseases), extracted causal relationships among these entities, and assembled them into early life-immune causal networks. These causal early life immune networks were denoised using GeneMania, enriched with data from the gene-disease association database DisGeNET and Gene Ontology resource tools (GO/GO-SLIM), inferred missing relationships and added expert knowledge to generate information-dense early life immune networks. Analysis of the six early life immune networks by PageRank, not only confirmed the central role of the "commonly used immune markers" (e.g., chemokines, interleukins,

Indexed as

AnimalsBiomarkersChemokinesChild DevelopmentComputational BiologyCytochrome P-450 CYP1A2Disease Models, AnimalForkhead Transcription FactorsGene Regulatory NetworksHumansImmune SystemImmune System DiseasesInfantInfant, NewbornMachine LearningBiomarkersChemokinesCytochrome P-450 CYP1A2Forkhead Transcription FactorsFOXP3 protein, humanbiomarkersearly lifeimmune networksmachine learningtext mining

Identifiers

PMID32362896
PMCPMC7182036
OpenAlexW3016426275

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.